QualityStocksNewsBreaks Archives - Page 664 of 1641

WednesdayApr 20, 2022 12:49 pm

QualityStocksNewsBreaks – Iconic Brands Inc.’s (ICNB) Bellissima Showcased at New York Bridal Fashion Week Runway Show

Iconic Brands (OTCQB: ICNB), a leader in the development, design and delivery of alcohol and non-alcohol beverages, today announced that its Bellissima Prosecco & Wines were featured at Lé Lauriér’s debut New York Bridal Fashion Week Runway Show. According to the update, the event was produced by “Sophisticated Weddings” Magazine at Capitale in New York on April 10, 2022. Also featured were tuxedos and suits by custom menswear clothier Alton Lane. Bellissima served as the event’s exclusive wine sponsor as the show – and its cocktail party - closed out this season’s New York Bridal Fashion Week. “It was a…

WednesdayApr 20, 2022 12:43 pm

QualityStocksNewsBreaks – Golden Matrix Group Inc. (NASDAQ: GMGI) Strengthens Global Footprint with Launch of Aggregate Gaming System

Golden Matrix Group (NASDAQ: GMGI), a developer and licensor of online gaming platforms, systems and gaming content, has gone live with GMX-Ag, its proprietary B2B aggregate gaming system. According to the announcement, the system has eight established online casino operators in six countries. The seamless turnkey iGaming system features the best casino, sportsbook and live-gaming content available through a single integration with the operators’ existing business systems; GMX-Ag also provides a single wallet for players. “The adoption of the GMX-Ag system is both strategic and timely,” said Golden Matrix CEO Brian Goodman in the press release. “It expands our B2B…

WednesdayApr 20, 2022 12:00 pm

QualityStocksNewsBreaks – Pressure BioSciences Inc. (PBIO) Featured on Stock Day Podcast

Pressure BioSciences (OTCQB: PBIO) (“PBI”), a leader in the development and sale of innovative, broadly enabling, pressure-based instruments, consumables and specialty testing services for the worldwide life sciences and other industries, was featured in a recent episode of The Stock Day Podcast. The company’s president and CEO Richard T. Schumacher joined Stock Day host Everett Jolly to discuss PBI’s revolutionary UST Platform and planned 2022 uplisting. “UST is an amazing technology as you and your listeners know. It is a very innovative technology with enormous potential in a myriad of industries. I suppose the easiest way to describe the power…

WednesdayApr 20, 2022 11:46 am

QualityStocksNewsBreaks – Silo Pharma Inc. (SILO) Produces First Batch of SPU-21 Liposomes for RA Study

Silo Pharma (OTCQB: SILO) is a development-stage biopharmaceutical company focused on the use of psychedelics as a therapeutic. The company today announced that it has produced its first batch of liposomes for use in a preclinical study that will be conducted by Frontage Laboratories, a CRO (contract research organization). According to the update, the ability of the SPU-21 to target inflamed epithelium suggest their potential use to target drug delivery. Silo’s novel joint homing peptides can be used to treat autoimmune diseases, which include but are not limited to rheumatoid arthritis (“RA”). This approach could enhance the therapeutic effect of…

TuesdayApr 19, 2022 3:49 pm

QualityStocksNewsBreaks – Mullen Automotive Inc.’s (NASDAQ: MULN) High-Performance, ‘Sexy’ FIVE Featured in The BUZZ Article

Mullen Automotive (NASDAQ: MULN), an emerging electric vehicle (“EV”) manufacturer, was featured in a recent article published by The BUZZ. The piece, titled “What is the Mullen FIVE & What’s Next for the EV Maker — Q&A,” features content from a roundtable discussion with Mullen’s CEO and Chairman David Michery, VP of marketing, Jason Putnam, and VP of vehicle engineering, Marian Petrelecan. “I believe that Mullen FIVE, to me, and to this company, is what the Model S was to Tesla (NASDAQ: TSLA),” Michery states. “The key factor – and people don’t focus on this key factor – is not…

TuesdayApr 19, 2022 3:42 pm

QualityStocksNewsBreaks – Pressure BioSciences Inc. (PBIO) to Present at Sequire Cannabis & Psychedelics Conference– SPYR Inc. (SPYR), Applied Magix Tease Upcoming Summer Sale with 50% Discounts

SPYR (OTCQB: SPYR), dba SPYR Technologies, a technology company and its subsidiary, Applied Magix Inc., has announced that, during its upcoming Applied Magix Summer Sale, select products will be available for up to 50% off. Applied Magix develops and resells Apple(R) ecosystem compatible products in the growing multibillion-dollar smart home and connected car markets. The summer sale is designed to reduce inventory in preparation for upcoming product updates while also providing consumers with some of the best prices on its products. Products offered through the sale include MagixDrive, MagixCharge Dual USB-C charger, Onvis C3 HomeKit Secure Video Camera and Onvis C1 Security…

TuesdayApr 19, 2022 3:35 pm

QualityStocksNewsBreaks – Pressure BioSciences Inc. (PBIO) to Present at Sequire Cannabis & Psychedelics Conference

Pressure BioSciences (OTCQB: PBIO) (“PBI”), a leader in the development and sale of innovative, broadly enabling, pressure-based instruments, consumables and specialty services to the worldwide biopharmaceuticals and other industries, today announced its participation as a presenter at the Sequire Cannabis & Psychedelics Investor Conference. The virtual event, taking place on April 20, 2022, will feature over 30 top public companies in the cannabis and psychedelics space. PBI’s president and CEO Richard T. Schumacher is scheduled to present, beginning at 10:30 a.m. ET, and will expand on the company's recent achievements in the nanoemulsification of CBD and other cannabinoids, as well…

TuesdayApr 19, 2022 2:58 pm

QualityStocksNewsBreaks – Lexaria Bioscience Corp. (NASDAQ: LEXX) Commences Its Most Comprehensive Study to Date

Lexaria Bioscience (NASDAQ: LEXX, LEXXW), a global innovator in drug delivery platforms, today announced that it has begun its multi-week human clinical hypertension study. The randomized, double blinded, placebo-controlled, cross-over study in 60 people, HYPER-H21-4, is the most comprehensive study ever undertaken by Lexaria. HYPER-H21-4 is designed to enhance Lexaria’s probability of success with its expected subsequent Investigational New Drug (“IND”) application filing to seek U.S. Food and Drug Administration (“FDA”) approval to commence registered clinical testing at phase I level or higher, to be determined in consultation with the FDA. The human study is also expected to enhance Lexaria’s…

TuesdayApr 19, 2022 2:48 pm

QualityStocksNewsBreaks – LQwD FinTech Corp. (TSX.V: LQWD) (OTCQB: LQWDF) Announces Continued Transaction Growth, Launch of Strategic India Node

LQwD FinTech (TSX.V: LQWD) (OTCQB: LQWDF), an emerging technology company developing payment infrastructure for the Bitcoin Lightning Network (“LN”), today announced two important milestones. These include the company’s ten global routing nodes now collectively reaching over 10,000 transactions forwarded, as well as its deployment of a new routing node in India. Tech savvy and densely populated, India is ranked second in countries seeing the fastest growth in cryptocurrency adoption globally and has one of the strongest internet markets in the world, with approximately 750 million users. “We are experiencing excellent transaction growth since launching our first nodes in November 2021,”…

TuesdayApr 19, 2022 2:29 pm

QualityStocksNewsBreaks – SRAX Inc. (NASDAQ: SRAX) Announces Panels and Featured Speakers for 4/20 Event

SRAX (NASDAQ: SRAX), a financial technology company that unlocks data and insights for publicly traded companies through Sequire, its software-as-a-service (“SaaS”) platform, today announced speakers for the Sequire Cannabis & Psychedelic Conference taking place on April 20, 2022. The event will showcase over 30 cannabis and psychedelic companies hosting 25 minute presentations, one-on-one investor meetings, and keynotes highlighting notable names in these spaces. The panels and featured speakers include a discussion on “Exploring the Value and Application of Botanical and Synthetic Formulations in Psychedelic Medicine,” in which Dr. Matt Johnson, Joel Stanley and David Drapkin will discuss clinical research on…

Site Search

Company Search

Category: QualityStocksNewsBreaks